Skip to Main Content

Paper Details

Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy.
Cancer Res
5
2023
-silenced cells, Cancer, IFN, IFN genes, MAVS, RIG-I, RNA, RNA Exonuclease XRN1, XRN1, XRN1-silenced cells, cancer, cancers, mice, patients, tumor, tumor cells
Author NameAffiliation
Henry YangCancer Science Institute of Singapore, National University of Singapore
Henry YangCancer Science Institute of Singapore, National University of Singapore
  • 1 - 2

Datasets

Release 1.2